NCT07764978
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07764978
Title Study of AZD0120 in Newly Diagnosed Multiple Myeloma Ineligible for ASCT (DURGA-5)
Acronym DURGA-5
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors AstraZeneca
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | SWE | POL | ITA | GBR | FRA | ESP | DNK | DEU | CAN | BRA | AUS


No variant requirements are available.